The role of HMGB1 in inflammation-mediated organ injury

Acta Anaesthesiologica Taiwanica

Volumn 51, Issue 1, 2013, Pages 28-33

  Asavarut, Paladd ^a   Zhao, Hailin ^a   Gu, Jianteng ^b   Ma, Daqing ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

HMGB1 protein; inflammation; organ injuries

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CREATINE KINASE; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STROMAL CELL DERIVED FACTOR 1; SUPEROXIDE DISMUTASE; TEPRENONE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE TOXICITY; ATHEROSCLEROSIS; CARDIOMYOPATHY; CHRONIC BRONCHITIS; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DEFENSE MECHANISM; DIABETIC NEPHROPATHY; EMPHYSEMA; GLOMERULOSCLEROSIS; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; INSULIN RELEASE; INTERNALIZATION; ISCHEMIA; LONGEVITY; MECHANICAL STRESS; MULTIPLE ORGAN FAILURE; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN INJURY; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRANSCYTOSIS; UPREGULATION;

ANIMALS; ATHEROSCLEROSIS; CARDIOMYOPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; GRAFT REJECTION; HMGB1 PROTEIN; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES; REPERFUSION INJURY; STRESS, MECHANICAL; TOLL-LIKE RECEPTOR 4;

EID: 84878258145     PISSN: 18754597     EISSN: 1875452X     Source Type: Journal    
DOI: 10.1016/j.aat.2013.03.007     Document Type: Review

References (102)

1. H. Yanai, T. Ban, Z. Wang, M.K. Choi, T. Kawamura, and H. Negishi HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses Nature 462 2009 99 103
2. H. Yanai, S. Chiba, T. Ban, Y. Nakaima, T. Onoe, and K. Honda Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs) Proc Natl Acad Sci U S A 108 2011 11542 11547
3. K.M. Livesey, R. Kang, P. Vernon, W. Buchser, P. Loughran, and S.C. Watkins p53/HMGB1 complexes regulate autophagy and apoptosis Cancer Res 72 2012 1996 2005
4. Y. Miyake, and S. Yamasaki Sensing necrotic cells Adv Exp Med Biol 738 2012 144 152
5. L. Vande Walle, T.D. Kanneganti, and M. Lamkanfi HMGB1 release by inflammasomes Virulence 2 2011 162 165
6. J.O. Thomas, and K. Stott H1 and HMGB1: Modulators of chromatin structure Biochem Soc Trans 40 2012 341 346
7. R. Chakraborty, K.H. Bhatt, and A. Sodhi Ultraviolet B induces high mobility group box 1 release from mouse peritoneal macrophages in vitro via caspase-1 mediated secretion pathway Immunobiology 218 2013 135 144
8. S. Shiozawa, and K. Tsumiyama Pathogenesis of rheumatoid arthritis and c-Fos/AP-1 Cell Cycle 8 2009 1539 1543
9. K. Hayakawa, J. Qiu, and E.H. Lo Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke Ann N Y Acad Sci 1207 2010 50 57
10. U. Andersson, and K.J. Tracey HMGB1 is a therapeutic target for sterile inflammation and infection Annu Rev Immunol 29 2011 139 162
11. H.E. Harris, U. Andersson, and D.S. Pisetsky HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease Nat Rev Rheumatol 8 2012 195 202
12. M. Schiraldi, A. Raucci, L.M. Munoz, E. Livoti, B. Celona, and E. Venereau HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 J Exp Med 209 2012 551 563
13. J.R. van Beijnum, W.A. Buurman, and A.W. Griffioen Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) Angiogenesis 11 2008 91 99
14. G.Y. Chen, J. Tang, P. Zheng, and Y. Liu CD24 and siglec-10 selectively repress tissue damage-induced immune responses Science 323 2009 1722 1725
15. D.J. Kaczorowski, A. Tsung, and T.R. Billiar Innate immune mechanisms in ischemia/reperfusion Front Biosci (Elite Ed) 1 2009 91 98
16. D. Tang, R. Kang, H.J. Zeh 3rd, and M.T. Lotze High-mobility group box 1, oxidative stress, and disease Antioxid Redox Signal 14 2011 1315 1335
17. A. Liu, O. Dirsch, H. Fang, J. Sun, H. Jin, and W. Dong HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat Histochem Cell Biol 135 2011 443 452
18. A. Tsung, J.R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, and X. Peng HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923
19. M. Pardo, N. Budick-Harmelin, B. Tirosh, and O. Tirosh Antioxidant defense in hepatic ischemia-reperfusion injury is regulated by damage-associated molecular pattern signal molecules Free Radic Biol Med 45 2008 1073 1083
20. K. Izuishi, A. Tsung, G. Jeyabalan, N.D. Critchlow, J. Li, and K.J. Tracey Cutting edge: High-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury J Immunol 176 2006 7154 7158
21. A. Liu, H. Jin, O. Dirsch, M. Deng, H. Huang, and M. Brocker-Preuss Release of danger signals during ischemic storage of the liver: A potential marker of organ damage? Mediators Inflamm 2010 2010 436145
22. R. Ramasamy, and A.M. Schmidt Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure Curr Heart Fail Rep 9 2012 107 116
23. S.F. Yan, R. Ramasamy, and A.M. Schmidt The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease Expert Rev Mol Med 11 2009 e9
24. N. Wang, X. Min, D. Li, P. He, and L. Zhao Geranylgeranylacetone protects against myocardial ischemia and reperfusion injury by inhibiting high-mobility group box 1 protein in rats Mol Med Rep 5 2012 521 524
25. S. Gratia, L. Kay, L. Potenza, A. Seffouh, V. Novel-Chate, and C. Schnebelen Inhibition of AMPK signalling by doxorubicin: At the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress Cardiovasc Res 95 2012 290 299
26. H.C. Volz, Z. Kaya, H.A. Katus, and M. Andrassy The role of HMGB1/RAGE in inflammatory cardiomyopathy Semin Thromb Hemost 36 2010 185 194
27. J. Rong, S. Ye, Z.K. Wu, G.X. Chen, M.Y. Liang, and H. Liu Controlled oxygen reperfusion protects the lung against early ischemia-reperfusion injury in cardiopulmonary bypasses by downregulating high mobility group box 1 Exp Lung Res 38 2012 183 191
28. U. Abdel-Rahman, P. Risteski, K. Tizi, S. Kerscher, S. Behjati, and K. Zwicker Hypoxic reoxygenation during initial reperfusion attenuates cardiac dysfunction and limits ischemia-reperfusion injury after cardioplegic arrest in a porcine model J Thorac Cardiovasc Surg 137 2009 978 982
29. C.Y. Lu, P.D. Winterberg, J. Chen, and J.R. Hartono Acute kidney injury: A conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules Pediatr Nephrol 27 2012 1847 1854
30. D. Kaminska, K. Koscielska-Kasprzak, D. Drulis-Fajdasz, A. Halon, W. Polak, and P. Chudoba Kidney ischemic injury genes expressed after donor brain death are predictive for the outcome of kidney transplantation Transplant Proc 43 2011 2891 2894
31. H. Wu, J. Ma, P. Wang, T.M. Corpuz, U. Panchapakesan, and K.R. Wyburn HMGB1 contributes to kidney ischemia reperfusion injury J Am Soc Nephrol 21 2010 1878 1890
32. T.A. Sutton, and P.C. Dagher Fueling the fire in acute kidney injury: Endothelial cells collect their toll Kidney Int 79 2011 267 269
33. J. Gu, P. Sun, H. Zhao, H.R. Watts, R.D. Sanders, and N. Terrando Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice Crit Care 15 2011 R153
34. J. Chen, R. John, J.A. Richardson, J.M. Shelton, X.J. Zhou, and Y. Wang Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury Kidney Int 79 2011 288 299
35. J. Chen, J.R. Hartono, R. John, M. Bennett, X.J. Zhou, and Y. Wang Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4 Kidney Int 80 2011 504 515
36. G.E. Chen, H. Wu, J. Ma, S.J. Chadban, and A. Sharland Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells Nephrol Dial Transplant 26 2011 3873 3881
37. J.B. Kim, C.M. Lim, Y.M. Yu, and J.K. Lee Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain J Neurosci Res 86 2008 1125 1131
38. Y.C. Wang, S. Lin, and Q.W. Yang Toll-like receptors in cerebral ischemic inflammatory injury J Neuroinflammation 8 2011 134
39. Q.W. Yang, F.L. Lu, Y. Zhou, L. Wang, Q. Zhong, and S. Lin HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent toll-like receptor 4 signaling J Cereb Blood Flow Metab 31 2011 593 605
40. Q.W. Yang, J. Xiang, Y. Zhou, Q. Zhong, and J.C. Li Targeting HMGB1/TLR4 signaling as a novel approach to treatment of cerebral ischemia Front Biosci (Schol Ed) 2 2010 1081 1091
41. Y. Huang, K. Xie, J. Li, N. Xu, G. Gong, and G. Wang Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits Brain Res 1378 2011 125 136
42. M. Fujioka, T. Nakano, K. Hayakawa, K. Irie, Y. Akitake, and Y. Sakamoto ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury Neurol Sci 33 2012 1107 1115
43. Q. Wang, F. Wang, X. Li, Q. Yang, X. Li, and N. Xu Electroacupuncture pretreatment attenuates cerebral ischemic injury through alpha7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats J Neuroinflammation 9 2012 24
44. Y.M. Ha, M.Y. Kim, M.K. Park, Y.S. Lee, Y.M. Kim, and H.J. Kim Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways Apoptosis 17 2012 463 474
45. G. Dvoriantchikova, E. Hernandez, J. Grant, A.R. Santos, H. Yang, and D. Ivanov The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion Invest Ophthalmol Vis Sci 52 2011 7187 7194
46. J. Qiu, J. Xu, Y. Zheng, Y. Wei, X. Zhu, and E.H. Lo High-mobility group box 1 promotes metalloproteinase-9 upregulation through toll-like receptor 4 after cerebral ischemia Stroke 41 2010 2077 2082
47. R. Yue, X. Yuan, X. Liu, J. Zhang, P. Jiang, and C. He Cynandione A mitigates ischemic injuries in rats with cerebral ischemia J Neurochem 121 2012 451 464
48. T. Itoh, S. Iwahashi, M. Shimoda, D. Chujo, M. Takita, and J.A. SoRelle High-mobility group box 1 expressions in hypoxia-induced damaged mouse islets Transplant Proc 43 2011 3156 3160
49. A.W. de Souza, J. Westra, P.C. Limburg, M. Bijl, and C.G. Kallenberg HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis Autoimmun Rev 11 2012 909 917
50. S. Morris-Rosenfeld, E. Blessing, M.R. Preusch, C. Albrecht, A. Bierhaus, and M. Andrassy Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression Eur J Clin Invest 41 2011 1164 1171
51. M.J. Meens, A. Pfenniger, and B.R. Kwak Risky communication in atherosclerosis and thrombus formation Swiss Med Wkly 142 2012 w13553
52. N. Kalinina, A. Agrotis, Y. Antropova, G. DiVitto, P. Kanellakis, and G. Kostolias Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: Role of activated macrophages and cytokines Arterioscler Thromb Vasc Biol 24 2004 2320 2325
53. S. Park, S.J. Yoon, H.J. Tae, and C.Y. Shim RAGE and cardiovascular disease Front Biosci 16 2011 486 497
54. K. Inoue, K. Kawahara, K.K. Biswas, K. Ando, K. Mitsudo, and M. Nobuyoshi HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques Cardiovasc Pathol 16 2007 136 143
55. S. Del Turco, and G. Basta An update on advanced glycation endproducts and atherosclerosis Biofactors 38 2012 266 274
56. J.A. Mosquera Role of the receptor for advanced glycation end products (RAGE) in inflammation Invest Clin 51 2010 257 268
57. J. Yang, C. Huang, J. Yang, H. Jiang, and J. Ding Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: A key role for TLR4/NF-kappaB signaling pathway Mol Cell Biochem 345 2010 189 195
58. H. Loppnow, L. Zhang, M. Buerke, M. Lautenschlager, L. Chen, and A. Frister Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures J Cell Mol Med 15 2011 994 1004
59. A. Albayrak, M.H. Uyanik, S. Cerrah, S. Altas, H. Dursun, and M. Demir Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment? Viral Immunol 23 2010 633 638
60. B.M. Fischer, E. Pavlisko, and J.A. Voynow Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation Int J Chron Obstruct Pulmon Dis 6 2011 413 421
61. H. Kanazawa, Y. Tochino, K. Asai, Y. Ichimaru, T. Watanabe, and K. Hirata Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD Eur J Clin Invest 42 2012 419 426
62. C. Hou, H. Zhao, L. Liu, W. Li, X. Zhou, and Y. Lv High mobility group protein B1 (HMGB1) in asthma: Comparison of patients with chronic obstructive pulmonary disease and healthy controls Mol Med 17 2011 807 815
63. M.B. Sukkar, L.G. Wood, M. Tooze, J.L. Simpson, V.M. McDonald, and P.G. Gibson Soluble RAGE is deficient in neutrophilic asthma and COPD Eur Respir J 39 2012 721 729
64. M. Lin, W.H. Yiu, H.J. Wu, L.Y. Chan, J.C. Leung, and W.S. Au Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy J Am Soc Nephrol 23 2012 86 102
65. M.R. Dasu, S. Devaraj, L. Zhao, D.H. Hwang, and I. Jialal High glucose induces toll-like receptor expression in human monocytes: Mechanism of activation Diabetes 57 2008 3090 3098
66. M. Li, L. Song, X. Gao, W. Chang, and X. Qin Toll-like receptor 4 on islet beta cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes Exp Mol Med 44 2012 260 267
67. R. Ramasamy, S.F. Yan, and A.M. Schmidt Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications Ann N Y Acad Sci 1243 2011 88 102
68. V. D'Agati, and A.M. Schmidt RAGE and the pathogenesis of chronic kidney disease Nat Rev Nephrol 6 2010 352 360
69. Y. Zhu, T. Shu, Y. Lin, H. Wang, J. Yang, and Y. Shi Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic beta-cells Biochem Biophys Res Commun 404 2011 159 165
70. P.C. Ren, Y. Zhang, X.D. Zhang, L.J. An, H.G. Lv, and J. He High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes Brain Res Bull 88 2012 332 337
71. A. Leelahavanichkul, Y. Huang, X. Hu, H. Zhou, T. Tsuji, and R. Chen Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing high mobility group box protein-1 Kidney Int 80 2011 1198 1211
72. N. Zhu, W. Yuan, Y. Zhou, J. Liu, J. Bao, and J. Hao High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal dialysis patients J Artif Organs 14 2011 125 132
73. A. Bruchfeld, A.R. Qureshi, B. Lindholm, P. Barany, L. Yang, and P. Stenvinkel High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD) Mol Med 14 2008 109 115
74. Y. Oyama, T. Hashiguchi, N. Taniguchi, S. Tancharoen, T. Uchimura, and K.K. Biswas High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy Lab Invest 90 2010 853 866
75. J.C. Leemans, L.M. Butter, W.P. Pulskens, G.J. Teske, N. Claessen, and T. van der Poll The role of toll-like receptor 2 in inflammation and fibrosis during progressive renal injury PLoS One 4 2009 e5704
76. H.S. Chiang, and M. Maric Lysosomal thiol reductase negatively regulates autophagy by altering glutathione synthesis and oxidation Free Radic Biol Med 51 2011 688 699
77. K. Belarbi, T. Jopson, D. Tweedie, C. Arellano, W. Luo, and N.H. Greig TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation J Neuroinflammation 9 2012 23
78. A. Vezzani, M. Maroso, S. Balosso, M.A. Sanchez, and T. Bartfai IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures Brain Behav Immun 25 2011 1281 1289
79. H.M. Gao, H. Zhou, F. Zhang, B.C. Wilson, W. Kam, and J.S. Hong HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration J Neurosci 31 2011 1081 1092
80. E. Leclerc, E. Sturchler, and S.W. Vetter The S100B/RAGE axis in alzheimer's disease Cardiovasc Psychiatry Neurol 2010 2010 539581
81. S.F. Yan, S.D. Yan, R. Ramasamy, and A.M. Schmidt Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation Ann Med 41 2009 408 422
82. E. Leclerc, E. Sturchler, S.W. Vetter, and C.W. Heizmann Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in alzheimer's disease Rev Neurosci 20 2009 95 110
83. S.H. Han, Y.H. Kim, and I.R.A.G.E. Mook-Jung The beneficial and deleterious effects by diverse mechanisms of actions Mol Cells 31 2011 91 97
84. J. Shimazaki, N. Matsumoto, H. Ogura, T. Muroya, Y. Kuwagata, and J. Nakagawa Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury Shock 37 2012 634 638
85. L. Zeng, A.Q. Zhang, W. Gu, K.H. Chen, D.P. Jiang, and L.Y. Zhang Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in southwest china Surgery 151 2012 427 436
86. C. Cai, Z. Cao, P.A. Loughran, S. Kim, S. Darwiche, and S. Korff Mast cells play a critical role in the systemic inflammatory response and end-organ injury resulting from trauma J Am Coll Surg 213 2011 604 615
87. S. Tsujii, T. Okabayashi, M. Shiga, Y. Takezaki, T. Sugimoto, and M. Kobayashi The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection World J Surg 36 2012 1122 1127
88. N. Ding, F. Wang, Y. Han, H. Xiao, L. Xu, and S. She Mitogen-activated protein kinase kinase 6 mediates mechanical stretch-induced high-mobility group box 1 protein expression in pulmonary alveolar epithelial cells J Trauma Acute Care Surg 72 2012 162 168
89. A. Matsuzawa, K. Saegusa, T. Noguchi, C. Sadamitsu, H. Nishitoh, and S. Nagai ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity Nat Immunol 6 2005 587 592
90. K. Suda, Y. Kitagawa, S. Ozawa, T. Miyasho, M. Okamoto, and Y. Saikawa Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy Dis Esophagus 20 2007 478 486
91. L. Duan, C.Y. Wang, J. Chen, Q. Gong, P. Zhu, and F. Zheng High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response Lab Invest 91 2011 43 53
92. S. Wang, C. Schmaderer, E. Kiss, C. Schmidt, M. Bonrouhi, and S. Porubsky Recipient toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling Dis Model Mech 3 2010 92 103
93. W. Wei, M. Chen, Y. Zhu, J. Wang, P. Zhu, and Y. Li Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts J Nutr Biochem 23 2012 1333 1340
94. D.A. Rao, and J.S. Pober Endothelial injury, alarmins, and allograft rejection Crit Rev Immunol 28 2008 229 248
95. Q. Gong, H. Zhang, J.H. Li, L.H. Duan, S. Zhong, and X.L. Kong High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice J Mol Med (Berl) 88 2010 1289 1298
96. S. Zhang, J. Zhong, P. Yang, F. Gong, and C.Y. Wang HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes Int J Clin Exp Pathol 3 2009 24 38
97. D.G. Craig, P. Lee, E.A. Pryde, G.S. Masterton, P.C. Hayes, and K.J. Simpson Circulating apoptotic and necrotic cell death markers in patients with acute liver injury Liver Int 31 2011 1127 1136
98. R.R. Zhou, S.S. Zhao, M.X. Zou, P. Zhang, B.X. Zhang, and X.H. Dai HMGB1 cytoplasmic translocation in patients with acute liver failure BMC Gastroenterol 11 2011 21
99. M.M. Zaldivar, M.L. Berres, H. Sahin, A. Nellen, D. Heinrichs, and P. Schmitz The chemokine receptor CXCR3 limits injury after acute toxic liver damage Lab Invest 92 2012 724 734
100. H. Hirano, T. Yoshioka, S. Yunoue, S. Fujio, H. Yonezawa, and T. Niiro TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6 Neuropathology 32 2012 628 637
101. S.H. Dave, J.S. Tilstra, K. Matsuoka, F. Li, R.A. DeMarco, and D. Beer-Stolz Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis J Leukoc Biol 86 2009 633 643
102. G. Gong, L.B. Yuan, L. Hu, W. Wu, L. Yin, and J.L. Hou Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1 Acta Pharmacol Sin 33 2012 11 18